22492996|t|Mitochondria-targeted catalase reduces abnormal APP processing, amyloid beta production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.
22492996|a|The purpose of this study was to investigate the protective effects of the mitochondria-targeted antioxidant catalase (MCAT) and lifespan extension in mice that express amyloid beta (Abeta). Using immunoblotting and immunostaining analyses, we measured the production of full-length amyloid precursor protein (APP), soluble APPalpha, C-terminal fragments CTF99 and CTF83, monomeric and oligomeric Abeta, Abeta deposits and beta site amyloid precursor protein cleaving enzyme 1 (BACE1), in different stages of disease progression in MCAT/AbetaPP and AbetaPP mice. Using quantitative reverse transcriptase polymerase chain reaction and immunostaining analyses, we studied the expression of catalase, BACE1, the Alzheimer's disease (AD) markers, synaptophysin, APP, neprilysin, insulin-degrading enzyme and transthyretin in MCAT, AbetaPP, MCAT/AbetaPP and wild-type (WT) mice. Using the high pressure liquid chromatography analysis of 8-hydroxy-2-deoxyguanosine, we measured oxidative DNA damage in the cerebral cortical tissues from MCAT, AbetaPP, MCAT/AbetaPP and WT mice. We found that the AbetaPP transgenic mice that carried the human MCAT gene lived 5 months longer than did the AbetaPP mice. We also found that the overexpression of MCAT in the brain sections from the MCAT/AbetaPP transgenic mice significantly correlated with a reduction in the levels of full-length APP, CTF99, BACE1, Abeta levels (40 and 42), Abeta deposits and oxidative DNA damage relative to the brain sections from the AbetaPP mice. Interestingly, we found significantly increased levels of soluble APPalpha and CTF83 in the MCAT/AbetaPP mice, relative to the AbetaPP mice. These data provide direct evidence that oxidative stress plays a primary role in AD etiopathology and that in MCAT mice express Abeta, MCAT prevents abnormal APP processing, reduces Abeta levels and enhances Abeta-degrading enzymes in mice at different ages, corresponding to different stages of disease progression. These findings indicate that mitochondria-targeted molecules may be an effective therapeutic approach to treat patients with AD.
22492996	22	30	catalase	Gene	12359
22492996	92	97	BACE1	Gene	23821
22492996	103	108	mouse	Species	10090
22492996	118	137	Alzheimer's disease	Disease	MESH:D000544
22492996	305	313	catalase	Gene	12359
22492996	347	351	mice	Species	10090
22492996	379	384	Abeta	Gene	11820
22492996	479	504	amyloid precursor protein	Gene	11820
22492996	593	598	Abeta	Gene	11820
22492996	600	605	Abeta	Gene	11820
22492996	619	672	beta site amyloid precursor protein cleaving enzyme 1	Gene	23821
22492996	674	679	BACE1	Gene	23821
22492996	728	732	MCAT	CellLine	CVCL:B1M7
22492996	733	740	AbetaPP	Gene	11820
22492996	745	752	AbetaPP	Gene	11820
22492996	753	757	mice	Species	10090
22492996	884	892	catalase	Gene	12359
22492996	894	899	BACE1	Gene	23821
22492996	905	924	Alzheimer's disease	Disease	MESH:D000544
22492996	926	928	AD	Disease	MESH:D000544
22492996	939	952	synaptophysin	Gene	20977
22492996	959	969	neprilysin	Gene	17380
22492996	971	995	insulin-degrading enzyme	Gene	15925
22492996	1000	1013	transthyretin	Gene	22139
22492996	1023	1030	AbetaPP	Gene	11820
22492996	1037	1044	AbetaPP	Gene	11820
22492996	1064	1068	mice	Species	10090
22492996	1128	1154	8-hydroxy-2-deoxyguanosine	Chemical	MESH:D000080242
22492996	1233	1240	AbetaPP	Gene	11820
22492996	1247	1254	AbetaPP	Gene	11820
22492996	1262	1266	mice	Species	10090
22492996	1286	1293	AbetaPP	Gene	11820
22492996	1305	1309	mice	Species	10090
22492996	1327	1332	human	Species	9606
22492996	1378	1385	AbetaPP	Gene	11820
22492996	1386	1390	mice	Species	10090
22492996	1474	1481	AbetaPP	Gene	11820
22492996	1493	1497	mice	Species	10090
22492996	1581	1586	BACE1	Gene	23821
22492996	1588	1593	Abeta	Gene	11820
22492996	1614	1619	Abeta	Gene	11820
22492996	1694	1701	AbetaPP	Gene	11820
22492996	1702	1706	mice	Species	10090
22492996	1800	1804	MCAT	CellLine	CVCL:B1M7
22492996	1805	1812	AbetaPP	Gene	11820
22492996	1813	1817	mice	Species	10090
22492996	1835	1842	AbetaPP	Gene	11820
22492996	1843	1847	mice	Species	10090
22492996	1930	1932	AD	Disease	MESH:D000544
22492996	1964	1968	mice	Species	10090
22492996	1977	1982	Abeta	Gene	11820
22492996	2031	2036	Abeta	Gene	11820
22492996	2057	2062	Abeta	Gene	11820
22492996	2084	2088	mice	Species	10090
22492996	2277	2285	patients	Species	9606
22492996	2291	2293	AD	Disease	MESH:D000544
22492996	Association	MESH:D000544	23821
22492996	Negative_Correlation	12359	23821
22492996	Association	MESH:D000544	12359

